Alphachymotrypsine is given with the intention of reducing soft tissue inflammation and oedema from abscesses and ulcers, or associated with traumatic injuries, and to promote liquefaction of secretions of the upper respiratory tract in patients suffering from asthma, bronchitis, pulmonary diseases and sinusitis.

Pack size Box of 20 tablets, 50 tablets.
Shelf-life 24 months
Composition Alphachymotrypsine
Dosage forms and strengths Tablet: 4.2 mg.
Product code :



  • Treatment of post traumatic,
  • Post-operative oedema,
  • Burn.


  • Orally (not chew): 2 tablets once, 3 – 4 times daily or sublingually: 4 – 6 tablets daily.


  • Orally or sublingually administered.
  • Known hypersensitive to any of the active substance or excipients of the product.
  • Patients with decreased alpha-1 antitrypsine (patients with COPD, especially emphysema and patients presenting with nephrotic syndrome).
  • Temporary side effects that may occur (but that should disappear when therapy is discontinued or dosage is reduced) include changes in the color, consistency, and odor of the stool. Some individuals may experience gastrointestinal disturbances, such as flatulence, a feeling of fullness, diarrhea, constipation, or nausea.
  • With high does, minor allergic reactions such as reddening of the skin may occur.
  • People who should not use enzyme therapy include those with hereditary clotting disorders such as hemophilia, those suffering from coagulation disturbances, those who are just about to or have undergone surgery, those receiving anticoagulant therapy, anyone suffering from protein allergies, patients has stomach ulcers.
  • Pregnant women or those breast-feeding.
  • Patients should be aware of how they react to drug before driving or operating machinery.